Speaking of coronavirus-driven revenue streams, let’s move on to the OG company making the big bucks out of this pandemic — that is, of course, Pfizer, the American pharmaceutical behind the hottest product in the market right now (ie Covid-19 vaccines). Pfizer (PFE) announced its vaccine generated $3.5b in sales in the first three months of 2021 alone, accounting for nearly 25% of its total $14.6b revenue.

The Big Pharma giant now expects revenues from the treatment (which was created in partnership with German drugmaker BioNTech) to reach $26b this year. Investors must be delighted, given that the company’s shares have been up nearly 2%.